Atlas Trials

Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

Clinical trial NCT00202917 · COMPLETED

Trial details

NCT number
NCT00202917
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hematologic Malignancies
Start date
2004-02-01
Primary completion
2009-07-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.